An assay for botulinum toxin types A, B and F that requires both functional binding and catalytic activities within the neurotoxin
暂无分享,去创建一个
[1] Xiaohua He,et al. Detection of botulinum neurotoxin-A activity in food by peptide cleavage assay. , 2008, International journal of food microbiology.
[2] M. Kalkum,et al. Attomolar Detection of Botulinum Toxin Type A in Complex Biological Matrices , 2008, PloS one.
[3] Valérie Gros,et al. Development and comparison of two immunoassay formats for rapid detection of botulinum neurotoxin type A. , 2007, Journal of immunological methods.
[4] T. Weil,et al. Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept , 2007, Proceedings of the National Academy of Sciences.
[5] R. Stevens,et al. A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4. , 2006, Journal of molecular biology.
[6] Eric A. Johnson,et al. SV2 Is the Protein Receptor for Botulinum Neurotoxin A , 2006, Science.
[7] Shashi K. Sharma,et al. The 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Neurotoxins. Workshop Review: Assays and Detection , 2006, Neurotoxicity Research.
[8] Leonard A. Smith,et al. Sequence Variation within Botulinum Neurotoxin Serotypes Impacts Antibody Binding and Neutralization , 2005, Infection and Immunity.
[9] M. Atassi,et al. Mapping of the Synaptosome-Binding Regions on the Heavy Chain of Botulinum Neurotoxin A By Synthetic Overlapping Peptides Encompassing the Entire Chain , 2004, The protein journal.
[10] James J. Schmidt,et al. Fluorigenic Substrates for the Protease Activities of Botulinum Neurotoxins, Serotypes A, B, and F , 2003, Applied and Environmental Microbiology.
[11] C. Quinn,et al. Expression and purification of catalytically active, non-toxic endopeptidase derivatives of Clostridium botulinum toxin type A. , 2002, Protein expression and purification.
[12] G. Schiavo,et al. Neurotoxins affecting neuroexocytosis. , 2000, Physiological reviews.
[13] P. Dunnigan,et al. Development of an In Vitro Bioassay for Clostridium botulinum Type B Neurotoxin in Foods That Is More Sensitive than the Mouse Bioassay , 1999, Applied and Environmental Microbiology.
[14] T. Nishiki,et al. Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins. , 1998, Microbial pathogenesis.
[15] C. Shone,et al. Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities , 1996, Journal of clinical microbiology.
[16] G. Schiavo,et al. The mechanism of action of tetanus and botulinum neurotoxins. , 1995, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.
[17] C. Shone,et al. Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity. , 1985, European journal of biochemistry.
[18] D. Sesardic,et al. Development of improved SNAP25 endopeptidase immuno-assays for botulinum type A and E toxins. , 2008, Journal of immunological methods.